Intake of copper has no effect on cognition in patients with mild Alzheimer’s disease: a pilot phase 2 clinical trial
Open Access
- 28 June 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neural Transmission
- Vol. 115 (8), 1181-1187
- https://doi.org/10.1007/s00702-008-0080-1
Abstract
Disturbed copper (Cu) homeostasis may be associated with the pathological processes in Alzheimer’s disease (AD). In the present report, we evaluated the efficacy of oral Cu supplementation in the treatment of AD in a prospective, randomized, double-blind, placebo-controlled phase 2 clinical trial in patients with mild AD for 12 months. Sixty-eight subjects were randomized. The treatment was well-tolerated. There were however no significant differences in primary outcome measures (Alzheimer’s Disease Assessment Scale, Cognitive subscale, Mini Mental Status Examination) between the verum [Cu-(II)-orotate-dihydrate; 8 mg Cu daily] and the placebo group. Despite a number of findings supporting the hypothesis of environmental Cu modulating AD, our results demonstrate that oral Cu intake has neither a detrimental nor a promoting effect on the progression of AD.Keywords
This publication has 30 references indexed in Scilit:
- Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s diseaseJournal of Neural Transmission, 2006
- Structure of the Alzheimer's Disease Amyloid Precursor Protein Copper Binding DomainJournal of Biological Chemistry, 2003
- Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and IronJournal of Biological Chemistry, 2002
- Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic MiceNeuron, 2001
- Characterization of Copper Interactions with Alzheimer Amyloid β PeptidesJournal of Neurochemistry, 2000
- Increased regional brain concentrations of ceruloplasmin in neurodegenerative disordersBrain Research, 1996
- The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)Science, 1996
- The βA4 amyloid precursor protein binding to copperFEBS Letters, 1994
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984